These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1621486

  • 21. Selective venous sampling directly from cavernous sinus in Cushing's syndrome.
    Teramoto A, Nemoto S, Takakura K, Sasaki Y, Machida T.
    J Clin Endocrinol Metab; 1993 Mar; 76(3):637-41. PubMed ID: 8383143
    [Abstract] [Full Text] [Related]

  • 22. Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease.
    De Sousa SMC, McCormack AI, McGrath S, Torpy DJ.
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):515-522. PubMed ID: 28626863
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [Abstract] [Full Text] [Related]

  • 24. [Determination of pituitary hormones in cerebrospinal fluid in normal subjects and in hypothalamo-pituitary diseases. Secreting or non-secreting pituitary adenoma, empty sella syndrome, hypothalamic syndromes].
    Turpin G, Heshmati HM, Roger M, Cesselin F, Lagoguey M, Baulieu JL, De Gennes JL.
    Ann Endocrinol (Paris); 1980 Dec; 41(1):21-30. PubMed ID: 7396391
    [Abstract] [Full Text] [Related]

  • 25. Stimulatory effect of oCRH on alpha-subunit secretion during petrosal sinus sampling in patients with Cushing's disease.
    Vignati F, Berselli ME, Boccardi E, Branca V, Loli P.
    Horm Metab Res; 1992 Nov; 24(11):524-7. PubMed ID: 1280612
    [Abstract] [Full Text] [Related]

  • 26. Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration.
    Colao A, Pivonello R, Ferone D, La Tessa G, Faggiano A, Facciolli G, Di Somma C, Merola B, Lombardi G.
    J Endocrinol Invest; 1998 Apr; 21(4):257-62. PubMed ID: 9624601
    [Abstract] [Full Text] [Related]

  • 27. [Localization of an ACTH-producing pituitary microadenoma using bilateral and simultaneous catheterization of the inferior petrosal sinus].
    Bohndorf K, Günther RW, Vorwerk D, Allolio B, Benker G, Winkelmann W, Windeck R, Schulte HM.
    Rofo; 1988 Mar; 148(3):275-8. PubMed ID: 2832891
    [Abstract] [Full Text] [Related]

  • 28. Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies.
    Merola B, Longobardi S, Colao A, Di Somma C, Ferone D, Di Rella F, Pivonello R, Covelli V, Annunziato L, Lombardi G.
    Neuroendocrinology; 1996 Nov; 64(5):393-7. PubMed ID: 8930939
    [Abstract] [Full Text] [Related]

  • 29. Internal jugular vein sampling in adrenocorticotropic hormone-dependent Cushing's syndrome: a comparison with inferior petrosal sinus sampling.
    Erickson D, Huston J, Young WF, Carpenter PC, Wermers RA, Bonelli FS, Powell CC.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):413-9. PubMed ID: 15049954
    [Abstract] [Full Text] [Related]

  • 30. Cavernous and inferior petrosal sinus sampling in the evaluation of ACTH-dependent Cushing's syndrome.
    Liu C, Lo JC, Dowd CF, Wilson CB, Kunwar S, Aron DC, Tyrrell JB.
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):478-86. PubMed ID: 15473881
    [Abstract] [Full Text] [Related]

  • 31. The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing's disease.
    Doppman JL, Chang R, Oldfield EH, Chrousos G, Stratakis CA, Nieman LK.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):533-40. PubMed ID: 10022412
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M, Yamaji T, Takaku F, Teramoto A, Fukushima T.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 40. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M, Jacobs RA, Aylwin SJ, Burrin JM, Dahia PL, Monson JP, Honegger J, Fahlbush R, Trainer PJ, Chew SL, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.